Skip to main content
Log in

Malignant peripheral nerve sheath tumors: The St. Jude Children's Research Hospital experience

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Malignant peripheral nerve sheath tumors (MPNSTs) are uncommon in young patients. To contribute to the understanding of these tumors, we reviewed the records of all patients treated for PNSTs at one institution over a 30-year period.

Methods: We reviewed the records of eight patients treated for benign PNSTs and 28 patients treated for 29 MPNSTs. We focused on the latter group, statistically testing several clinical factors for their significance in affecting survival.

Results: Five-year survival in patients with MPNSTs was 39%. The most significant prognostic factor was gross tumor resectability (p=0.0004). Five-year survival for patients with resectable tumors was 65%, whereas no patient with unresectable disease survived >25 months. Tumor grade, site, and patient race were also significant factors by univariate analysis but were not significant when adjusted for resectability.

Conclusion: Gross tumor resection is crucial in treating malignant PNSTs. Supplemental radiation therapy is recommended for positive microscopic margins. More effective treatment is still being sought for unresectable disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rao BN. Nonrhabdomyosarcoma in children: prognostic factors influencing survival.Semin Surg Oncol 1993;9:524–31.

    CAS  PubMed  Google Scholar 

  2. Trojanowski JQ, Klienman GM, Proppe KH. Malignant tumors of nerve sheath origin.Cancer 1980;46:1202–12.

    CAS  PubMed  Google Scholar 

  3. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity: a study of 43 cases.Cancer 1990;66:1253–65.

    CAS  PubMed  Google Scholar 

  4. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Drieson N, Persing JA. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 28 cases.Cancer 1993;71:1247–53.

    CAS  PubMed  Google Scholar 

  5. Storm FK, Eilber FR, Mirra J, Morton DL. Neurofibrosarcoma.Cancer 1980;45:126–9.

    CAS  PubMed  Google Scholar 

  6. Ducatman BS, Scheitnauer BW, Peipgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors: a clinicopathologic study of 120 cases.Cancer 1986;57:2006–21.

    CAS  PubMed  Google Scholar 

  7. Bruner JM. Peripheral nerve sheath tumors of the head and neck.Semin Diagn Pathol 1987;4:136–49.

    CAS  PubMed  Google Scholar 

  8. Maurer HM, Moon T, Donaldson S, Fernandez C, Gehan EA, Hammond D, Hays DM, et al. The Intergroup Rhabdomyosarcoma Study: a preliminary report.Cancer 1977;40:2015–26.

    CAS  PubMed  Google Scholar 

  9. Rao BN, Santana VM, Parham D, Pratt CB, Fleming ID, Hudson M, Fontanesi J, et al. Pediatric nonrhabdomyosarcomas of the extremities: influence of size, invasiveness, and grade on outcome.Arch Surg 1991;126:1490–5.

    CAS  PubMed  Google Scholar 

  10. Ricci A, Parham DM, Woodruff JM, Callihan T, Green A, Erlandson RA. Malignant peripheral nerve sheath tumors arising from ganglioneuromas.Am J Surg Pathol 1984;8:19–29.

    PubMed  Google Scholar 

  11. Coffin CM, Dehner LP. Peripheral neurogenic tumors of the soft tissues in children and adolescents: a clinicopathologic study of 139 cases.Pediatr Pathol 1989;9:387–407.

    CAS  PubMed  Google Scholar 

  12. Ghosh BC, Ghosh L, Huvos AG, Fortner JG. Malignant schwannoma: a clinicopathologic study.Cancer 1973;31:184–90.

    CAS  PubMed  Google Scholar 

  13. Sordillo PP, Helson L, Hadju SI, Magill GB, Kosloff C, Golbey RB, Beattie EJ. Malignant schwannoma—clinical characteristics, survival, and response to therapy.Cancer 1981;47:2503–9.

    CAS  PubMed  Google Scholar 

  14. Raney B, Schnaufer L, Ziegler M, Chatten J, Littman P, Jarrett P. Treatment of children with neurogenic sarcoma: experience at the Children's Hospital of Philadelphia.Cancer 1987;59:1–5.

    CAS  PubMed  Google Scholar 

  15. Hajdu SI. Peripheral nerve sheath tumors: histogenesis, classification, and prognosis.Cancer 1993;72:3549–52.

    CAS  PubMed  Google Scholar 

  16. Newbould MJ, Wilkinson N, Mene A. Post-radiation malignant peripheral nerve sheath tumour: a report of two cases.Histopathology 1990;17:263–5.

    CAS  PubMed  Google Scholar 

  17. Woodruff JM, Chernik NL, Smith MC, Millett WB, Foote FW. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “triton” tumors).Cancer 1973;32:426–39.

    CAS  PubMed  Google Scholar 

  18. Brooks JS, Freeman M, Enterline HT. Malignant “triton” tumors: natural history and immunohistochemistry of nine new cases with literature review.Cancer 1985;55:2543–9.

    CAS  PubMed  Google Scholar 

  19. Dewit L, Albus-Lutter CE, DeJong A, Voute PA. Malignant schwannoma with a rhabdomyoblastic component, a socalled triton tumor: a clinicopathologic study.Cancer 1986;58:1350–6.

    CAS  PubMed  Google Scholar 

  20. Woodruff JM, Christensen WN. Glandular peripheral nerve sheath tumors.Cancer 1993;72:3618–28.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeCou, J.M., Rao, B.N., Parham, D.M. et al. Malignant peripheral nerve sheath tumors: The St. Jude Children's Research Hospital experience. Annals of Surgical Oncology 2, 524–529 (1995). https://doi.org/10.1007/BF02307086

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02307086

Key Words

Navigation